I. Badell

发表

TNF-alpha and pathologic bone resorption.

E. Schwarz, R. O’Keefe, L. Xing, 2005, The Keio journal of medicine.

CD40‐Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates

A. Kirk, G. Korbutt, R. Rajotte, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1*

E. Wagner, E. Schwarz, K. Matsuo, 2007, Journal of Biological Chemistry.

Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin‐diabetic non‐human primates

C. Ricordi, N. Kenyon, A. Sambanis, 2018, Xenotransplantation.

T follicular helper cells in the generation of alloantibody and graft rejection

M. Ford, I. Badell, I. R. Badell, 2016, Current opinion in organ transplantation.

Immunosuppression in Transplantation

S. Knechtle, I. Badell, E. Page, 2014 .

Experience with a Novel Efalizumab‐Based Immunosuppressive Regimen to Facilitate Single Donor Islet Cell Transplantation

A. Kirk, C. Larsen, T. Pearson, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Nondepleting Anti‐CD40‐Based Therapy Prolongs Allograft Survival in Nonhuman Primates

K. Reimann, A. Kirk, C. Larsen, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Islet Xenotransplantation Using Gal‐Deficient Neonatal Donors Improves Engraftment and Function

A. Kirk, G. Korbutt, R. Rajotte, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Superior inhibition of alloantibody responses with selective CD28 blockade is CTLA‐4 dependent and T follicular helper cell specific

M. Ford, I. Badell, G. L. La Muraglia, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept and CD28 Costimulation Blockade: Preventing and Reducing Alloantibodies over the Long Term

C. Larsen, T. Pearson, I. Badell, 2019, Current Transplantation Reports.

Selective CD28 Blockade Results in Superior Inhibition of Donor‐Specific T Follicular Helper Cell and Antibody Responses Relative to CTLA4‐Ig

M. Ford, D. Liu, I. Badell, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CMV high‐risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept

A. Mehta, J. Hogan, C. Larsen, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.

E. Schwarz, L. Xing, B. Boyce, 2005, Arthritis and rheumatism.

LFA-1-specific therapy prolongs allograft survival in rhesus macaques.

A. Kirk, C. Larsen, M. Ford, 2010, The Journal of clinical investigation.

CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation

I. Badell, G. L. La Muraglia, Emma S Crichton, 2021, Transplantation direct.

Circulating T follicular helper cells are a biomarker of humoral alloreactivity and predict donor‐specific antibody formation after transplantation

M. Ford, I. Badell, G. L. La Muraglia, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Cytokines following SCT: indications and controversies

I. Badell, 2008, Bone Marrow Transplantation.

CTLA4Ig Prevents Alloantibody Formation Following Nonhuman Primate Islet Transplantation Using the CD40‐Specific Antibody 3A8

A. Kirk, C. Larsen, M. Ford, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept Conversion in Kidney After Liver Transplantation

C. Larsen, I. Badell, Octav Cristea, 2021, Transplantation direct.

Abatacept as rescue immunosuppression after calcineurin inhibitor treatment failure in renal transplantation

C. Larsen, I. Badell, A. Farris, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient

C. Larsen, I. Badell, R. Cole, 2019, Transplantation direct.

Domino liver transplantation in maple syrup urine disease: a case report and review of the literature.

R. Chung, S. Knechtle, C. Hughes, 2013, Transplantation proceedings.

TNFα and pathologic bone resorption

E. Schwarz, R. O’Keefe, L. Xing, 2005 .

Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial.

R. Elbein, Kirk A Easley, C. Larsen, 2021, Transplantation.

Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial

N. Shenvi, C. Larsen, I. Badell, 2023, Transplantation direct.

Every 2‐month belatacept maintenance therapy in kidney transplant recipients greater than 1‐year posttransplant: A randomized, noninferiority trial

J. Hanfelt, C. Larsen, I. Badell, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Single Donor-Derived Pseudomonas aeruginosa Pseudoaneurysms in Two Kidney Transplant Recipients: A Case Report of Dichotomous Allograft Outcomes.

I. Badell, M. F. Berger, I. R. Badell, 2017, Transplantation proceedings.

Alternative Immunomodulatory Strategies for Xenotransplantation: CD40/154 Pathway‐Sparing Regimens Promote Xenograft Survival

A. Kirk, G. Korbutt, R. Rajotte, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients

A. Mehta, C. Larsen, K. Newell, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Pathogen Stimulation History Impacts Donor‐Specific CD8+ T Cell Susceptibility to Costimulation/Integrin Blockade–Based Therapy

C. Larsen, M. Ford, A. Lukacher, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States

J. Hogan, C. Larsen, T. Pearson, 2021, Clinical transplantation.

The impact of belatacept on third‐party HLA alloantibodies in highly sensitized kidney transplant recipients

M. Kamoun, C. Larsen, M. Ford, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A Novel Monoclonal Antibody to CD40 Prolongs Islet Allograft Survival

K. Reimann, A. Kirk, R. Wang, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Memory Tfh cells drive donor-specific antibodies independent of memory B cells and primary germinal center and alloantibody formation.

M. Ford, I. Badell, Shan Zeng, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Belatacept and Sirolimus Prolong Nonhuman Primate Islet Allograft Survival: Adverse Consequences of Concomitant Alefacept Therapy

C. Larsen, I. Badell, F. Leopardi, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

2B4 (CD244) induced by selective CD28 blockade functionally regulates allograft-specific CD8+ T cell responses

S. Nadler, M. Ford, S. Krummey, 2014, The Journal of experimental medicine.

Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future

I. Badell, W. Kitchens, Christian P. Larsen, 2023, Kidney international reports.

Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.

M. Ford, I. Badell, Danya Liu, 2018, JCI insight.

LFA-1-specific therapy prolongs allograft survival in rhesus macaques.

A. Kirk, C. Larsen, M. Ford, 2010, Journal of Clinical Investigation.

CD40‐Specific Costimulation Blockade Enhances Neonatal Porcine Islet Survival in Nonhuman Primates

G. Korbutt, G. Rayat, C. Larsen, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.